Fig.7
Proposed model of Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting JAK 1/2
Fig.7 | Journal of Translational Medicine
Proposed model of Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting JAK 1/2